COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS, AMADEUS, CELLNEX, IAG, SACYR. EUROPA: BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’25 que se publicarán en España y Europa en los próximos días. Se mantienen las dudas Con la campaña de resultados entrando en su recta final, los principales índices europeos cerraron con pérdidas, destacando...
A director at Novartis AG sold 2,500 shares at 98.528CHF and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025 Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease modifying potentialExhibitor Spotlight to discuss role of CD38 cells across a range of immune-mediated kidney diseasesFelzartamab, an investigational anti-CD38 monoclonal antibody, is a potentially differentiated therapeutic candidate with promise for a broad ra...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAIXABANK, MELIÁ, SECTOR ELÉCTRICO, PUIG BRANDS, UNICAJA. EUROPA: AXA, BAYER, SECTOR BANCARIO, UNICREDIT. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’25 que se publicarán en España y Europa en los próximos días. Toma de beneficios post Bancos Centrales Las bolsas a ambos lados del Atlántico se decant...
Avolta: Q3 sales and EBITDA came in a shade below expectations, but cash generation exceeded expectations. Faster growth rate in North America in October.|Constellium: Results ahead of expectations, good Q4 expected, and guidance upgraded once again|Eramet : Q3 25 revenue lower than expected|Finnair: Guidance range tightened downwards amid higher costs and weaker demand|
Avolta : un T3 un peu en-dessous des attentes sur le CA et l’Ebitda mais meilleure sur la génération de cash. Accélération de la croissance en octobre en Amérique du Nord.|Constellium: Results ahead of expectations, good Q4 expected, and guidance upgraded once again|Eramet : CA T3 25 plus faible que prévu|Finnair: Guidance range tightened downwards amid higher costs and weaker demand|
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.